TKNO - Alpha Teknova, Inc. Stock Price, Fair Value and News

$4.79+0.37 (+8.37%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TKNO Price Action

Last 7 days

0.8%

Last 30 days

-5.7%

Last 90 days

13.0%

Trailing 12 Months

-40.9%

TKNO RSI Chart

TKNO Valuation

Market Cap

256.4M

Price/Earnings (Trailing)

-14.07

Price/Sales (Trailing)

6.44

EV/EBITDA

-21.54

Price/Free Cashflow

-24.45

TKNO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TKNO Fundamentals

TKNO Revenue

Revenue (TTM)

39.8M

Rev. Growth (Yr)

9.17%

Rev. Growth (Qtr)

1.62%

TKNO Earnings

Earnings (TTM)

-18.2M

Earnings Growth (Yr)

43.34%

Earnings Growth (Qtr)

-20.06%

TKNO Profitability

EBT Margin

-45.57%

Return on Equity

-25.08%

Return on Assets

-16.93%

Free Cashflow Yield

-4.09%

TKNO Investor Care

Shares Dilution (1Y)

0.42%

Diluted EPS (TTM)

-0.33

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	38.3M	38.9M	39.8M	0
2024	36.9M	34.9M	36.3M	37.7M
2023	39.4M	39.2M	36.7M	36.7M
2022	39.0M	42.3M	43.6M	41.4M
2021	32.7M	34.1M	35.5M	36.9M
2020	0	0	0	31.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Alpha Teknova, Inc.

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

CEO	Mr. Stephen Gunstream
WEBSITE	teknova.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	285

Alpha Teknova, Inc. Frequently Asked Questions

What is the ticker symbol for Alpha Teknova, Inc.? What does TKNO stand for in stocks?

TKNO is the stock ticker symbol of Alpha Teknova, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alpha Teknova, Inc. (TKNO)?

As of Wed Dec 03 2025, market cap of Alpha Teknova, Inc. is 256.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TKNO stock?

You can check TKNO's fair value in chart for subscribers.

Is Alpha Teknova, Inc. a good stock to buy?

The fair value guage provides a quick view whether TKNO is over valued or under valued. Whether Alpha Teknova, Inc. is cheap or expensive depends on the assumptions which impact Alpha Teknova, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TKNO.

What is Alpha Teknova, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, TKNO's PE ratio (Price to Earnings) is -14.07 and Price to Sales (PS) ratio is 6.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TKNO PE ratio will change depending on the future growth rate expectations of investors.